Wojtek Mydlarz, MD

Dr. Olga Charnaya is an assistant professor of Pediatrics at the Johns Hopkins University School of Medicine. She specializes in pediatric kidney transplantation but provides care for children with kidney disease of all types including hypertension, chronic kidney disease, dialysis, hematuria, and proteinuria.Dr. Charnaya completed her undergraduate degree at the University of Maryland in College Park, and a Master’s degree in Microbiology and Immunology at Georgetown University. Subsequently, she matriculated at the Ben-Gurion University of the Negev to complete her medical degree. Her residency training was completed at University of Maryland Medical Center where she also served as chief resident. Her subspecialty training in Pediatric Nephrology was completed at Children’s National Medical Center, after which she joined the faculty at Johns Hopkins in 2017. In addition to providing clinical care, Dr. Charnaya is pursuing a Ph.D. in clinical investigation at the Bloomberg School of Public Health, and is actively engaged in clinical research to improve outcomes for pediatric kidney transplant recipients. Specifically, Dr. Charnaya’s research is studying ways to incorporate high-resolution tissue typing into deceased donor kidney allocation using computational modeling to improve immunological matching while preserving pediatric priority and equity (racial and geographic) in access to transplantation.

Nyall London has a unique clinical practice focused on the care of patients with sinonasal and skull base cancers. As one of the few surgeons trained in both head and neck cancer surgery, as well as rhinology and skull base surgery, he offers patients comprehensive sinonasal tumor surgical care, including open and endoscopic approaches as well as neck dissection surgery. Dr. London has developed notable patient education events about the multidisciplinary and long-term care of patients with sinonasal malignancies. Additionally, he is an innovator of clinical trials for these rare tumors, with open clinical trial options available and multiple others in development. Internationally recognized for his expertise in the care of patients with sinonasal and skull base cancers, Dr. London was an associate editor for the first international consensus statement on sinonasal tumors, and was appointed president of the International Network for Sinonasal Cancer Research (2024–26). He directs a research laboratory at the National Cancer Institute/National Institutes of Health focused on therapeutic advances and mechanisms of sinonasal tumorigenesis. Dr. London has published more than 130 peer-reviewed research articles, reviews and book chapters, including co-first author publications in Nature, Nature Medicine, Science Translational Medicine and Nature Cell Biology. He earned his medical and doctoral degrees from the University of Utah, and completed his residency in otolaryngology–head and neck surgery at Johns Hopkins. He also accomplished a fellowship in open and endoscopic head and neck and skull base surgery at The Ohio State University, under the direction of Dr. Ricardo Carrau.